ResearcherUniversity of Kansas Medical CenterNo recent work listed

Qi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6353-9589; OpenAlex author ID A5100340125; NIH RePORTER profile ID 9616556. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 11

Papers, trials and grants by year

2017: 1 paper, 1 grant · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 3

Grants 1

New HuR inhibitor against pancreatic cancer EMT and CSCs R21CA198265 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ping Chen · 1 shared paper, 2022 · strength 0.19
- Paper Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly. DOI 10.3389/fonc.2022.870473 ↗
Tao Wang · 1 shared paper, 2022 · strength 0.19
- Paper Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly. DOI 10.3389/fonc.2022.870473 ↗
Tao Wei · 2 shared papers, 2017–2020 · strength 0.18
- Paper Patient-derived xenograft model engraftment predicts poor prognosis after surgery in patients with pancreatic cancer. DOI 10.1016/j.pan.2020.02.008 ↗
- Paper Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic can… DOI 10.1186/s12943-017-0689-5 ↗
Tingbo Liang · 2 shared papers, 2017–2020 · strength 0.18
- Paper Patient-derived xenograft model engraftment predicts poor prognosis after surgery in patients with pancreatic cancer. DOI 10.1016/j.pan.2020.02.008 ↗
- Paper Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic can… DOI 10.1186/s12943-017-0689-5 ↗
Xueli Bai · 2 shared papers, 2017–2020 · strength 0.18
- Paper Patient-derived xenograft model engraftment predicts poor prognosis after surgery in patients with pancreatic cancer. DOI 10.1016/j.pan.2020.02.008 ↗
- Paper Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic can… DOI 10.1186/s12943-017-0689-5 ↗
Jianxin Wang · 1 shared paper, 2020 · strength 0.11
- Paper Patient-derived xenograft model engraftment predicts poor prognosis after surgery in patients with pancreatic cancer. DOI 10.1016/j.pan.2020.02.008 ↗
Qi Zhang · 1 shared paper, 2020 · strength 0.11
- Paper Patient-derived xenograft model engraftment predicts poor prognosis after surgery in patients with pancreatic cancer. DOI 10.1016/j.pan.2020.02.008 ↗
Jin Li · 1 shared paper, 2020 · strength 0.11
- Paper Patient-derived xenograft model engraftment predicts poor prognosis after surgery in patients with pancreatic cancer. DOI 10.1016/j.pan.2020.02.008 ↗
Qi Zhang · 1 shared paper, 2017 · strength 0.07
- Paper Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic can… DOI 10.1186/s12943-017-0689-5 ↗
Qihan Fu · 1 shared paper, 2017 · strength 0.07
- Paper Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic can… DOI 10.1186/s12943-017-0689-5 ↗
Jiaqi Yang · 1 shared paper, 2017 · strength 0.07
- Paper Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic can… DOI 10.1186/s12943-017-0689-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.